MICHAEL R ZIEBELL
Broker in Arlington, MA
License number
Massachusetts 9517649
Issued Date
Oct 9, 2010
Expiration Date
Mar 4, 2015
Type
Salesperson
Address
Address
Arlington, MA 02474
Professional information
Assay For Pcsk9 Inhibitors
US Patent:
8206943, Jun 26, 2012
Filed:
Jun 29, 2009
Appl. No.:
12/493752
Inventors:
Brian M. Beyer - Matawan NJ, US
Thomas Hesson - Burlington MA, US
Hung V. Le - Rockaway NJ, US
Andrew J. Prongay - Billerica MA, US
Krishna Kalghatgi - Westborough MA, US
Jennifer Joanne Gesell - Allentown NJ, US
Richard N. Ingram - Scotch Plains NJ, US
Michael R. Ziebell - Arlington MA, US
Thomas Hesson - Burlington MA, US
Hung V. Le - Rockaway NJ, US
Andrew J. Prongay - Billerica MA, US
Krishna Kalghatgi - Westborough MA, US
Jennifer Joanne Gesell - Allentown NJ, US
Richard N. Ingram - Scotch Plains NJ, US
Michael R. Ziebell - Arlington MA, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C12Q 1/37
US Classification:
435 23
Abstract:
The present invention provides methods for identifying modulators of PCSK9, for example, using a variety of assay formats. Inhibitors of PCSK9 can be used for example, to treat diseases such as hyperlipidemia and related disorders.
Assay For Pcsk9 Inhibitors
US Patent:
2012021, Aug 23, 2012
Filed:
May 8, 2012
Appl. No.:
13/466418
Inventors:
Brian M. Beyer - Matawan NJ, US
Thomas Hesson - Burlington MA, US
Hung V. Le - Rockaway NJ, US
Andrew J. Prongay - Billerica MA, US
Krishna Kalghatgi - Westborough MA, US
Jennifer Joanne Gesell - Allentown NJ, US
Richard N. Ingram - Scotch Plains NJ, US
Michael R. Ziebell - Arlington MA, US
Thomas Hesson - Burlington MA, US
Hung V. Le - Rockaway NJ, US
Andrew J. Prongay - Billerica MA, US
Krishna Kalghatgi - Westborough MA, US
Jennifer Joanne Gesell - Allentown NJ, US
Richard N. Ingram - Scotch Plains NJ, US
Michael R. Ziebell - Arlington MA, US
International Classification:
C12Q 1/37, G01N 33/53, G01N 27/62, G01N 27/447, G01N 30/00
US Classification:
435 792, 435 23
Abstract:
The present invention provides methods for identifying modulators of PCSK9, for example, using a variety of assay formats. Inhibitors of PCSK9 can be used for example, to treat diseases such as hyperlipidemia and related disorders.